US EditionWHO asks India to check whether cough syrup linked to child deaths was exported
At least 17 children under five died from cough syrups containing diethylene glycol nearly 500 times the safe limit, prompting bans and criminal probes in multiple Indian states.
- On Wednesday the World Health Organization asked Indian authorities to confirm whether a cough syrup linked to 17 child deaths was exported, while New Delhi urged the public to avoid two more brands.
- After laboratory tests found high DEG levels on October 2, Coldrif medicine was banned after Tamil Nadu laboratory found 48.6% diethylene glycol, nearly 500 times the permitted limit.
- The Central Drugs Standard Control Organisation said inspections found firms failed to test every batch of medicinal ingredients as required by law on October 7, 2025.
- Police investigating Sresan have registered criminal charges and bans are in place, while central regulators recommended cancelling Sresan Pharmaceutical Manufacturer's licence amid arrests and suspensions.
- Exports have faced tighter testing since 2023 after over 140 child deaths linked to Indian syrups, and India's $50 billion pharmaceutical industry supplies 40% of US generics globally.
21 Articles
21 Articles
Arab News
The Frontier PostWHO seeks clarification from India if cough syrup linked to deaths was exported
Get the latest breaking news and headlines from the largest Arab News website. Get world news, sport news, business news, entertainment, lifestyle, video and photos.
WHO asks India to check whether cough syrup linked to child deaths was exported
Indian authorities advised the public to avoid two more brands of cough syrup on Wednesday following the deaths of 17 children aged under five linked to a toxic ingredient, and faced questions over whether any contaminated syrup was exported.
Drug Regulator Admits Manufacturing Lapses Amid Outrage Over Cough Syrup Deaths
India's top drug regulator has acknowledged serious lapses in pharmaceutical manufacturing practices, amid growing outrage over child deaths allegedly linked to contaminated cough syrups.
Centre mandates rigorous 'cough syrup' testing after child deaths from toxic batch
Following the deaths of around 20 children linked to contaminated Coldrif cough syrup, the Directorate General of Health Services has issued a stringent advisory to all states and Union Territories, directing them to enforce stricter testing protocols for pharmaceutical products. The regulator emphasised the urgent need for thorough batch testing of both raw materials and finished products, adherence to safety norms under the Drugs Rules, and so…
Coverage Details
Bias Distribution
- 66% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
